The innovative drugs developed by our partners focus on the field of oncology and are currently looking for cooperation opportunities around the world. The forms of cooperation are not limited to financial investment, out-licensing and joint development.
Projects | Indication | Discovery | Preclinical | IND | Phase 1 | Phase 2 | Phase 3 |
Anti-LAG3-ab | Solid Tumors |
|
|||||
SPHK1 Inhibitor | Prostate Cancer |
|
Should you be interested in cooperation, please do not hesitate to contact us.